The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.
Nuclear Hormone Receptor Coregulators In Action: Diversity For Shared Tasks
Abstract
The nuclear hormone receptors are transcriptional regulators that activate gene expression upon binding of their respective ligands. A new class of protein, termed coregulators, has emerged during the last few years. These proteins have the faculty to repress (corepressors) or to enhance (coactivators) the activity of genes regulated by nuclear hormone receptors in a ligand-dependent fashion. In this review we describe most of these coregulators and discuss their mode of action. In particular, we comment on the link between coregulators and histone acetylation, which is a crucial event in the transcriptional response within chromatin. We describe novel alternative pathways, which elicit the recruitment of coregulators independently of the presence of any ligand and speculate on how the convergence of ligand-dependent and -independent mechanisms might enhance the transcriptional response of target genes. Nuclear hormone receptors are ligand-inducible transcription factors that are involved in a number of physiological and cellular events (see Table 1 for nuclear receptor nomenclature). Together, they form a superfamily, which includes the classic steroid receptors (androgen, estrogen, glucocorticoid, mineralocorticoid, and progesterone receptors), the thyroid, vitamin D, and retinoid receptors, as well as many others that have been characterized more recently. All of them share common functional domains named A to F. The N-terminal A/B region is weakly conserved among the members of the superfamily, has a variable length, and contains an autonomous activation function (AF-1). The conserved C domain is the DNA-binding domain, which consists of two zinc-finger-like motifs. The D domain is a variable hinge. The multifunctional C-terminal half of the protein (domain E) encompasses the ligand-binding domain (LBD), a second activation function (AF-2), a dimerization domain, and a region involved in nuclear localization. The AF-2 autonomous activation domain (AF-2 AD) is composed of an amphipathic α-helix that is highly conserved among nuclear receptors and is critical for transcriptional activation (1–4). The most C-terminal region (domain F) is variable and has no known function. This domain is absent in some receptors such as the progesterone receptor (PR), peroxisome proliferator-activated receptors (PPAR), and retinoid receptors [retinoic acid receptor (RAR), retinoid X receptor (RXR)]. Nomenclature According to the Nuclear Receptors Nomenclature Committee, 1999 Nomenclature According to the Nuclear Receptors Nomenclature Committee, 1999 Transcriptional activation by both AF-1 and AF-2 of the estrogen receptor (ER) is cell type specific and relies on the promoter context of the hormone-response element (HRE) (5). This suggests the existence of different mediating or coactivating proteins, several of which have been identified to date (see below). These mediators interact with the LBD and some are capable of increasing the AF-2 response in a ligand-dependent fashion. On certain promoters, AF-1 and AF-2 must synergize to reach efficient transactivation. The observation of transcriptional interference or squelching between steroid hormone receptors provided evidence for the existence of limiting common transcriptional cofactors that mediate AF-2 function (6, 7). The subsequent biochemical identification of several nuclear receptor-interacting proteins in a ligand-dependent manner supported this hypothesis (8) (Table 2). These mediators or coactivators are required to achieve efficient transcription (reviewed in Refs. 9–11). Nuclear Receptor Cofactors—Part I Nuclear Receptor Cofactors—Part I Numerous potential receptor-interacting proteins were identified and described in the past few years (Table 2), and many others will certainly be discovered in the near future. This rapid increase has led to some confusion in the nomenclature and raised questions about the definition of a coactivator. A real coactivator must fulfill certain requirements. First it must interact directly with the activation domain of a nuclear receptor in an agonist-dependent manner (but not in the presence of an antagonist), leading to enhancement of the receptor activation function. Most of the potential cofactors meet this definition. A coactivator should also interact with components of the basal transcription machinery. Finally, coactivators should not enhance the basal transcriptional activity by their own, although they contain an autonomous activation function (12, 13). Indeed, in the absence of a nuclear hormone receptor, coactivators cannot be recruited to promoters and therefore cannot coactivate transcription. Here, we will first discuss some well characterized coactivators and then we will comment on proteins whose coactivator status is not clearly established. Among all the described coactivators to date, SRC-1 (steroid receptor coactivator 1) has attracted much attention. The human SRC-1 was first discovered as a ligand-dependent
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., & Nakatani, Y. (1996) · Cell · doi:10.1016/s0092-8674(00)82001-2 · Cited by 2,952
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily
Oñate, S. A., Tsai, S. Y., Tsai, M.-J., & O'Malley, B. W. (1995) · Science · doi:10.1126/science.270.5240.1354 · Cited by 2,387
Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S.-C., Heyman, R. A., Rose, D. W., Glass, C. K., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81118-6 · Cited by 2,150
A signature motif in transcriptional co-activators mediates binding to nuclear receptors
Heery, D. M., Kalkhoven, E., Hoare, S., & Parker, M. G. (1997) · Nature · doi:10.1038/42750 · Cited by 2,128
Hörlein, A. J., Näär, A. M., Heinzel, T., Torchia, J., Gloss, B., Kurokawa, R., Ryan, A., Kamei, Y., Söderström, M., Glass, C. K., et al. (1995) · Nature · doi:10.1038/377397a0 · Cited by 2,034
Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., et al. (1995) · Science · doi:10.1126/science.270.5241.1491 · Cited by 1,964
Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ
Nolte, R. T., Wisely, G. B., Westin, S., Cobb, J. E., Lambert, M. H., Kurokawa, R., Rosenfeld, M. G., Willson, T. M., Glass, C. K., & Milburn, M. V. (1998) · Nature · doi:10.1038/25931 · Cited by 1,958
The CBP co-activator is a histone acetyltransferase
Bannister, A. J., & Kouzarides, T. (1996) · Nature · doi:10.1038/384641a0 · Cited by 1,805
Cited by
Nuclear Hormone Receptors and Gene Expression
Aranda, A., & Pascual, A. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.1269 · Cited by 1,570
Transcriptional regulatory circuits controlling mitochondrial biogenesis and function
Kelly, D. P., & Scarpulla, R. C. (2004) · Genes & Development · doi:10.1101/gad.1177604 · Cited by 1,243
Molecular Cues to Implantation
Dey, S. K., Lim, H., Das, S. K., Reese, J., Paria, B. C., Daikoku, T., & Wang, H. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0020 · Cited by 1,105
Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators
Smith, C. L., & O’Malley, B. W. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0023 · Cited by 931
Androgen Receptor (AR) Coregulators: An Overview
Heinlein, C. A., & Chang, C. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0460 · Cited by 943
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898
“specific subset of cofactors (261, 262) that may allow the GR to cooperate, perhaps even in a DNA-binding independent way, with other LPS- or TNF-activated transcription factors in the I B- -promoter.”
BackgroundTranscriptional Regulation of Metabolism
Desvergne, B., Michalik, L., & Wahli, W. (2006) · Physiological Reviews · doi:10.1152/physrev.00025.2005 · Cited by 892
Feige, J. N., Gelman, L., Michalik, L., Desvergne, B., & Wahli, W. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.12.002 · Cited by 786
Self-citationThe Human Histone Deacetylase Family
Gray, S. G., & Ekström, T. J. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5080 · Cited by 546
PPAR Signaling in the Control of Cardiac Energy Metabolism
Barger, P. M., & Kelly, D. P. (2000) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(00)00077-3 · Cited by 506
Rajapakse, N., Silva, E., & Kortenkamp, A. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.02110917 · Cited by 476
Activation of hepatic stellate cells - a key issue in liver fibrosis
Reeves, H. (2002) · Frontiers in Bioscience · doi:10.2741/reeves · Cited by 423
Degradation of MyoD Mediated by the SCF (MAFbx) Ubiquitin Ligase
Tintignac, L. A., Lagirand, J., Batonnet, S., Sirri, V., Leibovitch, M. P., & Leibovitch, S. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411346200 · Cited by 405
Phenobarbital Response Elements of Cytochrome P450 Genes and Nuclear Receptors
Sueyoshi, T., & Negishi, M. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.123 · Cited by 362
Genome-Wide Identification of High-Affinity Estrogen Response Elements in Human and Mouse
Bourdeau, V., Deschênes, J., Métivier, R., Nagai, Y., Nguyen, D., Bretschneider, N., Gannon, F., White, J. H., & Mader, S. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0441 · Cited by 360
NSD1 is essential for early post-implantation development and has a catalytically active SET domain
Rayasam, G. V. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg288 · Cited by 342
Lee, G., Elwood, F., McNally, J., Weiszmann, J., Lindstrom, M., Amaral, K., Nakamura, M., Miao, S., Cao, P., Learned, R. M., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200743200 · Cited by 319
Cracking the Estrogen Receptor's Posttranslational Code in Breast Tumors
Le Romancer, M., Poulard, C., Cohen, P., Sentis, S., Renoir, J.-M., & Corbo, L. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0016 · Cited by 313
Vanden Berghe, W., Vermeulen, L., De Wilde, G., De Bosscher, K., Boone, E., & Haegeman, G. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00412-3 · Cited by 303
PGC-1, a versatile coactivator
Knutti, D., & Kralli, A. (2001) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00457-x · Cited by 298
Greschik, H., Wurtz, J.-M., Sanglier, S., Bourguet, W., van Dorsselaer, A., Moras, D., & Renaud, J.-P. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00444-6 · Cited by 291
Regulation of the transcriptional coactivator PGC-1 via MAPK-sensitive interaction with a repressor
Knutti, D., Kressler, D., & Kralli, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171184698 · Cited by 271
Maglich, J. M., Sluder, A., Guan, X., Shi, Y., McKee, D. D., Carrick, K., Kamdar, K., Willson, T. M., & Moore, J. T. (2001) · Genome Biology · doi:10.1186/gb-2001-2-8-research0029 · Cited by 266
The Function of TIF2/GRIP1 in Mouse Reproduction Is Distinct from Those of SRC-1 and p/CIP
Gehin, M., Mark, M., Dennefeld, C., Dierich, A., Gronemeyer, H., & Chambon, P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.16.5923-5937.2002 · Cited by 262
Fernandes, I., Bastien, Y., Wai, T., Nygard, K., Lin, R., Cormier, O., Lee, H. S., Eng, F., Bertos, N. R., Pelletier, N., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00014-5 · Cited by 255
Finck, B. N., & Kelly, D. P. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2061 · Cited by 160
Reiterer, G., Toborek, M., & Hennig, B. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.7.1711 · Cited by 72
Glucocorticoid and thyroid hormone receptors in mitochondria of animal cells
Scheller, K., Seibel, P., & Sekerist, C. E. (2003) · International review of cytology · doi:10.1016/s0074-7696(02)22011-2 · Cited by 73
Mechanisms of brain glucocorticoid resistance in stress-induced psychopathologies
Merkulov, V. M., Merkulova, T. I., & Bondar, N. P. (2017) · Biochemistry (Moscow) · doi:10.1134/s0006297917030142 · Cited by 65
Androgen Receptor Regulates Expression of Skeletal Muscle–Specific Proteins and Muscle Cell Types
Altuwaijri, S., Lee, D. K., Chuang, K.-H., Ting, H.-J., Yang, Z., Xu, Q., Tsai, M.-Y., Yeh, S., Hanchett, L. A., Chang, H.-C., et al. (2004) · Endocrine · doi:10.1385/endo:25:1:27 · Cited by 58
Brassinosteroids Plant counterparts to animal steroid hormones?
Clouse, S. D. (2002) · Vitamins & Hormones · doi:10.1016/s0083-6729(02)65065-4 · Cited by 40
Metadata
- Authors
- Robyr, D.
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2000-03-01
- Volume
- 14
- Issue
- 3
- Pages
- 329-347
- ISSN
- 0888-8809 (ISSN-L)
- OpenAlex
- W2131103656
- Cited by
- 381
- References
- 148
- FWCI
- 30.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.